Drug Price Trends for PHENDIMETRAZINE ER

Average Pharmacy Cost for PHENDIMETRAZINE ER

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
PHENDIMETRAZINE ER 105 MG CAP	72989-0409-30	2.86214	EACH	2024-12-18
PHENDIMETRAZINE ER 105 MG CAP	72989-0409-30	2.86732	EACH	2024-11-20
PHENDIMETRAZINE ER 105 MG CAP	72989-0409-30	2.85622	EACH	2024-10-23
PHENDIMETRAZINE ER 105 MG CAP	69543-0409-30	2.85622	EACH	2024-10-23
PHENDIMETRAZINE ER 105 MG CAP	72989-0409-30	2.85465	EACH	2024-09-18
PHENDIMETRAZINE ER 105 MG CAP	69543-0409-30	2.85465	EACH	2024-09-18

Market Analysis and Price Projections for Phendimetrazine ER

Introduction to Phendimetrazine ER

Phendimetrazine, marketed in its extended-release (ER) form, is a sympathomimetic amine used as an adjunct therapy for the short-term management of exogenous obesity. It belongs to the class of anorectics or anorexigenics, which are drugs designed to suppress appetite and increase metabolism[4].

Market Size and Growth Projections

The Phendimetrazine Tartrate market has been experiencing steady growth, driven by increasing health consciousness and the rising obesity epidemic.

• Current Market Size: As of 2024, the Phendimetrazine Tartrate market size was valued at USD 371.24 million[1].
• Future Projections: The market is projected to grow to USD 497.50 million by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 5.00%[1].

Key Market Segments

The Phendimetrazine Tartrate market can be segmented based on several factors:

By Type

• Tablets: Available in various strengths, including 35 mg.
• Capsules: Extended-release capsules, typically 105 mg[1].

By Application

• Hospitals: Used in clinical settings for obesity management.
• Clinics: Prescribed in outpatient settings for weight loss programs[1].

Driving Factors

Several factors are driving the growth of the Phendimetrazine Tartrate market:

Obesity Epidemic

The increasing prevalence of obesity globally is a significant driver. As more people seek medical interventions for weight loss, the demand for medications like Phendimetrazine ER is rising[1].

Health Consciousness

Growing awareness about health and wellness is prompting more individuals to seek professional help for weight management, contributing to the market's growth[1].

Price Analysis

The pricing of Phendimetrazine ER varies based on the dosage form, strength, and location.

Oral Tablets

• A supply of 14 tablets of 35 mg Phendimetrazine oral tablets can cost around $10.46, with the price per unit decreasing as the quantity increases[2].

Extended Release Capsules

• The cost for 30 extended-release capsules of 105 mg Phendimetrazine can start at approximately $1.55 per capsule, totaling around $46.50 for a 30-capsule supply[5].

Patient Assistance and Copay Programs

While there are no specific patient assistance programs (PAPs) listed for Phendimetrazine, patients may benefit from general discount cards and copay programs offered by pharmacies and healthcare providers.

• Discount Cards: Programs like the Drugs.com discount card can help reduce the cost of Phendimetrazine ER at participating pharmacies[2].

Mechanism of Action and Side Effects

Understanding the mechanism of action and potential side effects is crucial for both patients and healthcare providers.

Mechanism of Action

Phendimetrazine acts by stimulating the central nervous system, activating the alpha-adrenergic system, and releasing norepinephrine and dopamine, which help in suppressing appetite and increasing metabolism[4].

Side Effects

Common side effects include headache, overstimulation, high blood pressure, insomnia, rapid or irregular heart rate, and tremor. More severe side effects can include arrhythmias, hypertension, and gastrointestinal symptoms like nausea and vomiting[2][4].

Comparison with Other Weight Loss Medications

Phendimetrazine ER is part of a broader landscape of weight loss medications, each with its own cost and efficacy profile.

Cost Comparison

• Phentermine: One of the oldest and most widely used weight loss medications, phentermine can be significantly cheaper, with prices starting at around $10 for a supply[3].
• GLP-1 Receptor Agonists: Medications like Wegovy are much more expensive, with an annual estimated net price of $13,600[3].

Efficacy Comparison

• Phentermine: Patients may lose about 5% of their body weight using phentermine.
• Phentermine-topiramate: This combination can result in a 5-10% body weight loss.
• Phendimetrazine ER: While specific weight loss percentages are not widely documented, it is known to be effective in short-term weight management[3].

Upcoming Trends and Developments

The weight loss medication market is evolving with new candidates and technologies.

New Medications

• GLP-1 Inhibitors: Companies like Lilly and Pfizer are developing new GLP-1 inhibitors, which may offer alternative or more effective treatments for obesity[3].

Market Dynamics

The demand for weight loss medications is expected to continue growing, driven by consumer demand and the increasing prevalence of obesity. This trend is likely to influence the pricing and availability of Phendimetrazine ER and other weight loss medications.

Key Takeaways

• Market Growth: The Phendimetrazine Tartrate market is projected to grow to USD 497.50 million by 2031 with a CAGR of 5.00%.
• Driving Factors: The obesity epidemic and increasing health consciousness are key drivers.
• Pricing: Prices vary by dosage form and quantity, with extended-release capsules and tablets available at different price points.
• Mechanism and Side Effects: Phendimetrazine ER works by stimulating the central nervous system and can have various side effects.
• Comparison with Other Medications: It is part of a broader market with varying costs and efficacies.

FAQs

What is the projected market size of Phendimetrazine Tartrate by 2031?

The Phendimetrazine Tartrate market is expected to reach USD 497.50 million by 2031[1].

What is the CAGR of the Phendimetrazine Tartrate market?

The market is expected to exhibit a CAGR of 5.00% till 2031[1].

What are the key segments of the Phendimetrazine Tartrate market?

The market is segmented by type (tablets and capsules) and application (hospitals and clinics)[1].

How does Phendimetrazine ER work?

Phendimetrazine ER works by stimulating the central nervous system, activating the alpha-adrenergic system, and releasing norepinephrine and dopamine to suppress appetite and increase metabolism[4].

What are the common side effects of Phendimetrazine ER?

Common side effects include headache, overstimulation, high blood pressure, insomnia, rapid or irregular heart rate, and tremor[2][4].

Are there any patient assistance programs for Phendimetrazine ER?

There are no specific patient assistance programs listed for Phendimetrazine ER, but general discount cards and copay programs may be available[2].

How does the cost of Phendimetrazine ER compare to other weight loss medications?

Phendimetrazine ER is generally more affordable than GLP-1 receptor agonists like Wegovy but may be comparable or slightly more expensive than older medications like phentermine[3].

What are the upcoming trends in the weight loss medication market?

New GLP-1 inhibitors and other weight loss medications are being developed, which may offer alternative or more effective treatments for obesity[3].

Sources

1. Proficient Market Insights: Phendimetrazine Tartrate Market Size, Scope And Forecast Report.
2. Drugs.com: Phendimetrazine Prices, Coupons, Copay Cards & Patient Assistance.
3. Obesity Medicine Association: Top Weight Loss Medications.
4. DrugBank: Phendimetrazine: Uses, Interactions, Mechanism of Action.
5. PharmacyChecker: Phendimetrazine Tartrate Er Prices - U.S. & International.